| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | QL-XII-47 | GDSC1000 | pan-cancer | AAC | -0.054 | 0.08 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.073 | 0.1 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.087 | 0.1 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.085 | 0.1 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.086 | 0.1 |
| mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | 0.048 | 0.1 |
| mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | -0.075 | 0.1 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | -0.046 | 0.1 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | -0.047 | 0.1 |